TLR4 and metabolic dysfunction-associated steatotic liver disease: One study reported that intestinal bacteria modulation by probiotic administration via repression of lipopolysaccharides and consequent suppression of TLR-4 and NF-kB pathways could prevent or treat NAFLD [56].